Welcome to our dedicated page for Futurefuel news (Ticker: FF), a resource for investors and traders seeking the latest updates and insights on Futurefuel stock.
FutureFuel Corp (NYSE: FF) delivers innovative solutions in specialty chemicals and biofuels through its integrated manufacturing capabilities. This news hub provides investors and industry stakeholders with essential updates on corporate developments, financial performance, and market positioning.
Access timely press releases covering earnings announcements, production milestones, and strategic initiatives in both chemical manufacturing and biodiesel operations. Our curated collection includes regulatory filings, partnership disclosures, and operational updates that impact FF's position in renewable energy and specialty chemicals markets.
Key content focuses on custom chemical synthesis contracts, biofuel production trends, and sustainability initiatives. Stay informed about market-moving developments including new product launches, facility upgrades, and industry compliance matters through verified primary sources.
Bookmark this page for direct access to FutureFuel's official communications and third-party analysis. Regular updates ensure you maintain current awareness of FF's dual-segment operations in evolving chemical and renewable energy sectors.
FutureFuel (NYSE: FF) will release its third quarter 2025 financial results after market close on Monday, November 10, 2025. The announcement provides the date and timing for the earnings release but does not include financial figures or guidance.
FutureFuel (NYSE: FF) announced operational updates on Oct 15, 2025 covering chemicals, biodiesel, and corporate location.
Chemicals: startup of a new specialty chemical production investment to vertically integrate a key on‑site raw material; production will ramp through Q4 2025 and is expected to contribute more materially to sales beginning Q1 2026.
Biodiesel: production was idled in June 2025 due to regulatory uncertainty and high input costs; with clarified IRA 45Z support and modest input improvements, the company says it may be able to restart biodiesel production sometime in Q4 2025, subject to market conditions.
Headquarters: FutureFuel will close its remote St. Louis office and consolidate corporate activities and key personnel at its Batesville, Arkansas production facility.
FutureFuel Corp (NYSE:FF), a manufacturer of custom and performance chemicals and biofuels, announced that Terrance C.Z. Egger will not seek re-election to the Board of Directors at the upcoming annual meeting on November 11, 2025.
Egger, who has served on the board since 2015, was a member of the Audit Committee and chair of the Nominating/Corporate Governance Committee. His departure is not due to any disputes with the company. Following his retirement, the Board will be reduced to eight members.
FutureFuel Corp. (NYSE:FF) reported challenging Q2 2025 financial results, with revenues declining 51% to $35.7 million compared to Q2 2024. The company posted a net loss of $10.4 million ($0.24 per share), down from a net income of $9.6 million in Q2 2024. Adjusted EBITDA was negative $9.8 million.
Due to high feedstock prices and market challenges, FutureFuel temporarily idled its biodiesel plant in June 2025. The company's Chemicals segment experienced slower performance but has expanded its pipeline with new projects expected to commence in Q4 2025 and Q1 2026. A new production facility for backward integration is nearing completion in Q3.
The company maintains its quarterly dividend of $0.06 per share and reports $95.2 million in cash and cash equivalents as of June 30, 2025. Capital expenditures increased to $9.5 million in 2025, primarily due to the construction of a custom chemical plant.
FutureFuel Corp. (NYSE:FF), a manufacturer of custom and performance chemicals and biofuels, has announced it will release its second quarter 2025 financial results after market close on Monday, August 11, 2025.
FutureFuel Corp. (NYSE: FF) reported challenging Q1 2025 financial results, with revenues declining 70% to $17.5 million compared to $58.3 million in Q1 2024. The company recorded a net loss of $17.6 million ($0.40 per share), down from a net income of $4.3 million ($0.10 per share) year-over-year. Adjusted EBITDA fell to ($16.1) million from $7.1 million.
The performance decline was primarily attributed to lower biofuel volumes due to a strategic maintenance turnaround at their Batesville, Arkansas facilities from December through March. The company maintains a quarterly dividend of $0.06 per share. Despite current challenges, FutureFuel is progressing with a new backward-integrated capacity project expected to launch in late summer 2025. The company's cash position stood at $97.1 million as of March 31, 2025.
FutureFuel Corp. (NYSE: FF), a manufacturer of custom and performance chemicals and biofuels, has announced it will release its first quarter 2025 financial results after market close on Monday, May 12, 2025.
FutureFuel Corp. (NYSE: FF) has expanded its Board of Directors to nine members with the appointment of Pamela R. Butcher as a Class C director, effective April 3, 2025. Butcher brings extensive chemical industry experience, having served as CEO, President, and COO of Pilot Chemical Corp. from 2010 to 2021, and holding various leadership positions at Dow Chemical Company from 1980 to 2009.
Butcher currently serves on the boards of J.M. Huber and Pilot Chemical Corp. Her compensation will align with FutureFuel's 2024 director compensation arrangements, pro-rated for her first year. Additionally, she will receive an option to purchase 10,000 shares of company common stock, expiring in April 2030, under the company's 2017 Omnibus Incentive Plan.
FutureFuel Corp. (NYSE: FF) reported its 2024 financial results with notable declines across key metrics. The company posted net income of $15.5 million ($0.35 per diluted share), down from $37.4 million in 2023. Annual revenues decreased 34% to $243.3 million, while Adjusted EBITDA fell to $17.6 million from $35.0 million.
Q4 2024 showed significant decreases with revenues at $61.5 million (down 33%) and net income at $2.8 million ($0.06 per diluted share). The company faced challenges including chemical customer destocking and lower biodiesel production yields, leading to a plant shutdown extending through Q1 2025. Capital expenditures increased to $14,668 in 2024, primarily for a new custom chemical plant expected to complete mid-2025.
The company maintained its quarterly dividend of $0.06 per share and reported cash and cash equivalents of $109,541, down from $219,444 in 2023 after a special dividend payment of $2.50 per share.